Repaglinide treatment is associated with significantly less sever ehypoglycaelnic events compared to sulphonylureas..Smedegaard kristensen J; Brown Fraudsen K; Bayer T; et al;.Diabetologia.1999,
Repaglinide treatment is associated with significantly less sever ehypoglycaelnic events compared to sulphonylureas..Smedegaard kristensen J; Brown Fraudsen K; Bayer T; et al;.Diabetologia.1999,